NEW PUBLICATION - Mitochondrial disease, mitophagy, and cellular distress in methylmalonic acidemia
A new publication from Dr. Luciani and Dr. Froese groups!
Check it out here
Abstract
Mitochondria—the intracellular powerhouse in which nutrients are converted into energy in the form of ATP or heat—are highly dynamic, double-membraned organelles that harness a plethora of cellular functions that sustain energy metabolism and homeostasis. Exciting new discoveries now indicate that the maintenance of this ever changing and functionally pleiotropic organelle is particularly relevant in terminally differentiated cells that are highly dependent on aerobic metabolism. Given the central role in maintaining metabolic and physiological homeostasis, dysregulation of the mitochondrial network might therefore confer a potentially devastating vulnerability to high-energy requiring cell types, contributing to a broad variety of hereditary and acquired diseases. In this Review, we highlight the biological functions of mitochondria-localized enzymes from the perspective of understanding—and potentially reversing—the pathophysiology of inherited disorders affecting the homeostasis of the mitochondrial network and cellular metabolism. Using methylmalonic acidemia as a paradigm of complex mitochondrial dysfunction, we discuss how mitochondrial directed-signaling circuitries govern the homeostasis and physiology of specialized cell types and how these may be disturbed in disease. This Review also provides a critical analysis of affected tissues, potential molecular mechanisms, and novel cellular and animal models of methylmalonic acidemia which are being used to develop new therapeutic options for this disease. These insights might ultimately lead to new therapeutics, not only for methylmalonic acidemia, but also for other currently intractable mitochondrial diseases, potentially transforming our ability to regulate homeostasis and health.
More news
- NEW PUBLICATION - Tubular cell plasticity—new hope for autosomal dominant polycystic kidney disease?
- Prof. Nikola Biller-Andorno became a member of the EU ethics group!
- NEW PUBLICATION - Defective Cystinosin, Aberrant Autophagy−Endolysosome Pathways, and Storage Disease: Towards Assembling the Puzzle
- Congratulations to the ITINERARE Grants winners!
- NEW PUBLICATION - AQP1 Promoter Variant, Water Transport and Outcome in Peritoneal Dialysis
- NEW PUBLICATION - Spectrum and characterization of bi-allelic variants in MMAB causing cblB-type methylmalonic aciduria
- NEW PUBLICATION - Mendelian randomization to assess causality between uromodulin, blood pressure and chronic kidney disease
- Registration to the ITINERARE Symposium 2021 is open!
- ITINERARE@Scientifica 2021
- NEW PUBLICATION - An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis
- NEW PUBLICATION - Absence of MMACHC in peripheral retinal cells does not lead to an ocular phenotype in mice
- NEW PUBLICATION - A systematic review of moral reasons on orphan drug reimbursement
- NEW PUBLICATION - Assessing transport across the peritoneal membrane: Precision medicine in dialysis
- NEW PUBLICATION - Defects in KCNJ16 Cause a Novel Tubulopathy with Hypokalemia, Salt Wasting, Disturbed Acid-Base Homeostasis, and Sensorineural Deafness
- NEW PUBLICATION - Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: First revision
- NEW PUBLICATION - Receptor-Mediated Endocytosis and Differentiation in Proximal Tubule Cell Systems
- NEW PUBLICATION - PIEZO2, a mechanosensor in the urinary bladder
- ITINERARE kick-off meeting May 18th (closed event)
- URPP kick-off event March 23rd